About Tot Biopharm
Tot Biopharm is a company based in Suzhou (China) founded in 2010.. Tot Biopharm has raised $108 million across 3 funding rounds from investors including Yuanda Financial Holdings, CDIB Capital Group and CenterLab. Tot Biopharm operates in a competitive market with competitors including Syngene, Abzena, Patheon, Piramal Group and Maravai Life Sciences, among others.
- Headquarter Suzhou, China
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$108 M (USD)
in 3 rounds
-
Latest Funding Round
$102 M (USD), Series B
Aug 08, 2018
-
Investors
Yuanda Financial Holdings
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tot Biopharm
Tot Biopharm has successfully raised a total of $108M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $102 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $102.0M
-
First Round
First Round
(01 Jun 2010)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2018 | Amount | Series B - Tot Biopharm | Valuation | 99fund | |
| Jun, 2018 | Amount | Series B - Tot Biopharm | Valuation | CDIB Capital Group |
|
| Jun, 2010 | Amount | Series A - Tot Biopharm | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tot Biopharm
Tot Biopharm has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Yuanda Financial Holdings, CDIB Capital Group and CenterLab. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and private equity firm
|
Founded Year | Domain | Location | |
|
Chengwei Capital is recognized as an early venture capital firm in China.
|
Founded Year | Domain | Location | |
|
Cathay Capital is engaged in global investment and transformation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tot Biopharm
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tot Biopharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tot Biopharm Comparisons
Competitors of Tot Biopharm
Tot Biopharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syngene, Abzena, Patheon, Piramal Group and Maravai Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| domain | founded_year | HQ Location |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| domain | founded_year | HQ Location |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| domain | founded_year | HQ Location |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| domain | founded_year | HQ Location |
Provides enabling tools and services in the life sciences research and bio-production industries
|
|
| domain | founded_year | HQ Location |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tot Biopharm
Frequently Asked Questions about Tot Biopharm
When was Tot Biopharm founded?
Tot Biopharm was founded in 2010.
Where is Tot Biopharm located?
Tot Biopharm is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Is Tot Biopharm a funded company?
Tot Biopharm is a funded company, having raised a total of $108M across 3 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Jun 01, 2010.
Who are the top competitors of Tot Biopharm?
Tot Biopharm's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
Who are Tot Biopharm's investors?
Tot Biopharm has 8 investors. Key investors include Yuanda Financial Holdings, CDIB Capital Group, CenterLab, Vivo Capital, and Chengwei Capital.